Paul Meister

Paul is a partner at Novalis LifeSciences, a life-sciences venture fund and co-founder of Liberty Lane Partners, a private investment company. He serves as Chairman of Arbor Biotechnologies and Amneal Pharmaceuticals and is on the board of Aptiv PLC, Quanterix, Ori Biotech, Sherlock Biosciences and several other early-stage life science tools and diagnostic companies.

Previously Paul served as Chairman of Thermo Fisher Scientific and Vice Chairman of Fisher Scientific International. He also served as Chairman and CEO of inVentiv Health (now Syneos Heath), and president of MacAndrews and Forbes. Paul earned a MBA from Northwestern University and a BA from the University of Michigan and serves on the board of Michigan’s Life Sciences Institute, and the Provost’s Advisory Council.